Local inhibition of mastocalcergy by calciphylactic challengers.
D000085:Acetates; D000818:Animals; D002114:Calcinosis / Q000139:chemically induced / Q000188:drug therapy*; D002115:Calciphylaxis / Q000188:drug therapy*; D002118:Calcium / Q000032:analysis; D002364:Caseins / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use*; D002712:Chlorides / Q000627:therapeutic use; D002857:Chromium / Q000627:therapeutic use; D005260:Female; D007501:Iron / Q000627:therapeutic use; D007854:Lead / Q000032:analysis; D008407:Mast Cells / Q000187:drug effects; D010710:Phosphates / Q000627:therapeutic use; D010758:Phosphorus / Q000032:analysis; D011113:Polymyxins; D051381:Rats; D012867:Skin / Q000032:analysis; D012964:Sodium / Q000627:therapeutic use
D000085:Acetates; D002364:Caseins; D002614:Chelating Agents; D002712:Chlorides; D010710:Phosphates; D011113:Polymyxins; D002857:Chromium; D010758:Phosphorus; D007854:Lead; D012964:Sodium; D007501:Iron; D002118:Calcium